NDC00024-0749-01: DIATRIZOATE MEGLUMINE INJECTION.
DIATRIZOATE MEGLUMINE INJECTION. Key specifications include primary_container_type: BOTTLE, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10, primary_container_content_quantity: 150.000 MILLILITERS, part_name_assigned_by_controlling_agency: DIATRIZOATE MEGLUMINE INJECTION USP 60% 150ML BOTTLE 10S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-163-1283, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | 150 ML IN OVERSIZE 200 ML BOTTLE WITH SOLUTION ADMINISTRATION SET; ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT |
| primary_container_type | BOTTLE |
| pharmaceutical_vehicle_type | AQUEOUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 150.000 MILLILITERS |
| part_name_assigned_by_controlling_agency | DIATRIZOATE MEGLUMINE INJECTION USP 60% 150ML BOTTLE 10S |
| NSN | 6505-01-163-1283 |
| PRIMARY CONTAINER CONTENT QUANTITY | 150.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | 150 ML IN OVERSIZE 200 ML BOTTLE WITH SOLUTION ADMINISTRATION SET; ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | DIATRIZOATE MEGLUMINE INJECTION USP 60% 150ML BOTTLE 10S |
| PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |